Diagnostica Stago, Inc.

Diagnostica Stago, Inc. (DSI) is a global leader in hemostasis and thrombosis diagnostics and testing. The company develops, manufactures, and distributes coagulation analyzers, reagents, quality control materials, and related services for clinical laboratory and hospital settings. Stago's product portfolio includes the STA product line of automated coagulation analyzers (including STA Max Generation 3), complementary reagents for hemostasis testing, and consumables for thrombosis and hemostasis assessment. The company provides comprehensive support through quality control programs (My Daily QC, My Expert QC, My Qualiris EQA), technical services, continuing education (Stago EdVantage), and webinar programs covering new tests and markers in hemostasis. Stago maintains ISO and regulatory compliance for its analyzers and reagents, with recent FDA clearance of the STA Max Generation 3. The company serves hospitals, clinical laboratories, and diagnostic centers across the United States and operates as part of the international Stago Group with subsidiaries in multiple countries. Customer support includes digital portals (My Personal Space), peer comparison networks (Clarity Peer Group), and access to safety documentation and instructions for use.